BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 36762719)

  • 1. Progress of Metal-Based Anticancer Chemotherapeutic Agents in Last two Decades and their Comprehensive Biological (DNA/RNA Binding, Cleavage and Cytotoxicity Activity) Studies.
    Arjmand F; Yasir Khan H; Tabassum S
    Chem Rec; 2023 Mar; 23(3):e202200247. PubMed ID: 36762719
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advances in anticancer alkaloid-derived metallo-chemotherapeutic agents in the last decade: Mechanism of action and future prospects.
    Ansari MF; Khan HY; Tabassum S; Arjmand F
    Pharmacol Ther; 2023 Jan; 241():108335. PubMed ID: 36567056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Water soluble transition metal [Ni(II), Cu(II) and Zn(II)] complexes of
    Khursheed S; Siddique HR; Tabassum S; Arjmand F
    Dalton Trans; 2022 Aug; 51(31):11713-11729. PubMed ID: 35852297
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis of novel coumarin nucleus-based DPA drug-like molecular entity: In vitro DNA/Cu(II) binding, DNA cleavage and pro-oxidant mechanism for anticancer action.
    Khan S; Malla AM; Zafar A; Naseem I
    PLoS One; 2017; 12(8):e0181783. PubMed ID: 28763458
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design and synthesis of enantiomeric (R)- and (S)-copper(II) and diorganotin(IV)-based antitumor agents: their in vitro DNA binding profile, cleavage efficiency and cytotoxicity studies.
    Arjmand F; Muddassir M; Yousuf I
    J Photochem Photobiol B; 2014 Jul; 136():62-71. PubMed ID: 24857791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mixed ligand copper(II) dicarboxylate complexes: the role of co-ligand hydrophobicity in DNA binding, double-strand DNA cleavage, protein binding and cytotoxicity.
    Loganathan R; Ramakrishnan S; Ganeshpandian M; Bhuvanesh NS; Palaniandavar M; Riyasdeen A; Akbarsha MA
    Dalton Trans; 2015 Jun; 44(22):10210-27. PubMed ID: 25954774
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mixed ligand copper(II) complexes of N,N-bis(benzimidazol-2-ylmethyl)amine (BBA) with diimine co-ligands: efficient chemical nuclease and protease activities and cytotoxicity.
    Loganathan R; Ramakrishnan S; Suresh E; Riyasdeen A; Akbarsha MA; Palaniandavar M
    Inorg Chem; 2012 May; 51(10):5512-32. PubMed ID: 22559171
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Copper complexes based on chiral Schiff-base ligands: DNA/BSA binding ability, DNA cleavage activity, cytotoxicity and mechanism of apoptosis.
    Zhou XQ; Li Y; Zhang DY; Nie Y; Li ZJ; Gu W; Liu X; Tian JL; Yan SP
    Eur J Med Chem; 2016 May; 114():244-56. PubMed ID: 26994692
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent Development of Copper (II) Complexes of Polypyridyl Ligands in Chemotherapy and Photodynamic Therapy.
    Rani J J; Roy S
    ChemMedChem; 2023 Apr; 18(8):e202200652. PubMed ID: 36773314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biological evaluation, molecular docking and DNA interaction studies of coordination compounds gleaned from a pyrazolone incorporated ligand.
    Arunadevi A; Porkodi J; Ramgeetha L; Raman N
    Nucleosides Nucleotides Nucleic Acids; 2019; 38(9):656-679. PubMed ID: 30990358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Copper (II)-based halogen-substituted chromone antitumor drug entities: Studying biomolecular interactions with ct-DNA mediated by sigma hole formation and cytotoxicity activity.
    Arjmand F; Khursheed S; Roisnel T; Siddique HR
    Bioorg Chem; 2020 Nov; 104():104327. PubMed ID: 33142405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cu(ii) and V(iv)O complexes with tri- or tetradentate ligands based on (2-hydroxybenzyl)-l-alanines reveal promising anticancer therapeutic potential.
    Ribeiro N; Bulut I; Cevatemre B; Teixeira C; Yildizhan Y; André V; Adão P; Pessoa JC; Acilan C; Correia I
    Dalton Trans; 2021 Jan; 50(1):157-169. PubMed ID: 33290472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platinum, palladium, gold and ruthenium complexes as anticancer agents: Current clinical uses, cytotoxicity studies and future perspectives.
    Lazarević T; Rilak A; Bugarčić ŽD
    Eur J Med Chem; 2017 Dec; 142():8-31. PubMed ID: 28442170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anticancer potency of copper(II) complexes of thiosemicarbazones.
    Singh NK; Kumbhar AA; Pokharel YR; Yadav PN
    J Inorg Biochem; 2020 Sep; 210():111134. PubMed ID: 32673842
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA binding, cleavage and cytotoxicity studies of three mononuclear Cu(II) chloro-complexes containing N-S donor Schiff base ligands.
    Parsekar SU; Fernandes J; Banerjee A; Chouhan OP; Biswas S; Singh M; Mishra DP; Kumar M
    J Biol Inorg Chem; 2018 Dec; 23(8):1331-1349. PubMed ID: 30302601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improving Cytotoxicity against Breast Cancer Cells by Using Mixed-Ligand Ruthenium(II) Complexes of 2,2'-Bipyridine, Amino Acid, and Nitric Oxide Derivatives as Potential Anticancer Agents.
    Gaspari APS; da Silva RS; Carneiro ZA; de Carvalho MR; Carvalho I; Pernomian L; Ferreira LP; Ramos LCB; de Souza GA; Formiga ALB
    Anticancer Agents Med Chem; 2021; 21(12):1602-1611. PubMed ID: 33081686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platinum(II) and Copper(II) complexes of asymmetric halogen-substituted [NN'O] ligands: Synthesis, characterization, structural investigations and antiproliferative activity.
    Amiri Rudbari H; Saadati A; Aryaeifar M; Blacque O; Cuevas-Vicario JV; Cabral R; Raposo LR; Fernandes AR
    Bioorg Chem; 2022 Feb; 119():105556. PubMed ID: 34959175
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design, Synthesis, and Biological Evaluation of Benzimidazole-Derived Biocompatible Copper(II) and Zinc(II) Complexes as Anticancer Chemotherapeutics.
    AlAjmi MF; Hussain A; Rehman MT; Khan AA; Shaikh PA; Khan RA
    Int J Mol Sci; 2018 May; 19(5):. PubMed ID: 29772746
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ternary dinuclear copper(II) complexes of a hydroxybenzamide ligand with diimine coligands: the 5,6-dmp ligand enhances DNA binding and cleavage and induces apoptosis.
    Ramakrishnan S; Shakthipriya D; Suresh E; Periasamy VS; Akbarsha MA; Palaniandavar M
    Inorg Chem; 2011 Jul; 50(14):6458-71. PubMed ID: 21671566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhancement in intramolecular interactions and in vitro biological activity of a tripodal tetradentate system upon complexation.
    Tyagi N; Viji M; Karunakaran SC; Varughese S; Ganesan S; Priya S; Saneesh Babu PS; Nair AS; Ramaiah D
    Dalton Trans; 2015 Sep; 44(35):15591-601. PubMed ID: 26244289
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.